Literature DB >> 10854040

Elevated UTP and CTP content in cultured neurons from HPRT-deficient transgenic mice.

S Brosh1, P Boer, O Sperling, E Zoref-Shani.   

Abstract

Hypoxanthine-guanine phosphoribosyltransferase (EC 2.4.2.8.; HPRT) catalyzes the salvage synthesis of inosine-5'-monophosphate (IMP) and guanosine-5'-monophosphate (GMP) from the purine bases hypoxanthine and guanine, respectively. Complete deficiency of HPRT activity is associated with the Lesch-Nyhan syndrome (LNS), characterized by excessive purine production and severe neurological manifestations. The etiology of the metabolic consequences of HPRT deficiency is clarified, but that of the neurological manifestations is not yet understood. HPRT-deficient mice represent an experimental animal model of LNS. In search for a possible metabolic abnormality in LNS brains, connecting the neurological deficit to HPRT deficiency, the purine and pyrimidine nucleotide content of cultured neurons, prepared from HPRT-deficient transgenic mice, was now determined. The HPRT-deficient neuronal cultures exhibited a significantly elevated content of the pyrimidine nucleotides UTP (1.33-fold the normal level, p = 0.0002) and CTP (1.28-fold the normal level, p = 0.02), but normal content of the purine nucleotides ATP and GTP. This abnormality in neuronal pyrimidine nucleotide content may be associated with the pathophysiology of the neurological deficit in LNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854040     DOI: 10.1385/JMN:14:1-2:087

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  16 in total

1.  A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION.

Authors:  M LESCH; W L NYHAN
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

2.  Abnormal purine and pyrimidine nucleotide content in primary astroglia cultures from hypoxanthine-guanine phosphoribosyltransferase-deficient transgenic mice.

Authors:  D Pelled; O Sperling; E Zoref-Shani
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

3.  Regulation of de novo purine synthesis in human lymphoblasts. Similar rates of de novo synthesis during growth by normal cells and mutants deficient in hypoxanthine-guanine phosphoribosyltransferase activity.

Authors:  M S Hershfield; J E Seegmiller
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

4.  Developmental changes in purine nucleotide metabolism in cultured rat astroglia.

Authors:  E Zoref-Shani; Y Bromberg; G Lilling; I Gozes; S Brosh; Y Sidi; O Sperling
Journal:  Int J Dev Neurosci       Date:  1995-12       Impact factor: 2.457

Review 5.  The Lesch-Nyhan syndrome.

Authors:  W L Nyhan
Journal:  Annu Rev Med       Date:  1973       Impact factor: 13.739

6.  Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome.

Authors:  K G Lloyd; O Hornykiewicz; L Davidson; K Shannak; I Farley; M Goldstein; M Shibuya; W N Kelley; I H Fox
Journal:  N Engl J Med       Date:  1981-11-05       Impact factor: 91.245

7.  Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.

Authors:  H A Jinnah; B E Wojcik; M Hunt; N Narang; K Y Lee; M Goldstein; J K Wamsley; P J Langlais; T Friedmann
Journal:  J Neurosci       Date:  1994-03       Impact factor: 6.167

8.  Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.

Authors:  H A Jinnah; P J Langlais; T Friedmann
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

Review 9.  The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome.

Authors:  A A Baumeister; G D Frye
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

10.  Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.

Authors:  J Jankovic; T C Caskey; J T Stout; I J Butler
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

View more
  4 in total

1.  Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients.

Authors:  Lynette D Fairbanks; Gabriella Jacomelli; Vanna Micheli; Tina Slade; H Anne Simmonds
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

2.  Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling.

Authors:  Martin Göttle; Heike Burhenne; Diane Sutcliffe; H A Jinnah
Journal:  J Neurochem       Date:  2013-08-18       Impact factor: 5.372

3.  New biomarkers for early diagnosis of Lesch-Nyhan disease revealed by metabolic analysis on a large cohort of patients.

Authors:  Irène Ceballos-Picot; Aurélia Le Dantec; Anaïs Brassier; Jean-Philippe Jaïs; Morgan Ledroit; Julie Cahu; Hang-Korng Ea; Bertrand Daignan-Fornier; Benoît Pinson
Journal:  Orphanet J Rare Dis       Date:  2015-01-23       Impact factor: 4.123

4.  Reduced levels of dopamine and altered metabolism in brains of HPRT knock-out rats: a new rodent model of Lesch-Nyhan Disease.

Authors:  Stephen Meek; Alison J Thomson; Linda Sutherland; Matthew G F Sharp; Julie Thomson; Valerie Bishop; Simone L Meddle; Yoann Gloaguen; Stefan Weidt; Karamjit Singh-Dolt; Mia Buehr; Helen K Brown; Andrew C Gill; Tom Burdon
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.